Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT06514651
MAQ-001 in Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 6, 2024
Completion: Jun 30, 2028